DLX6 and renal cell carcinoma: DLX6-AS1 was also found to promote renal cell carcinoma progression via miR-26a/phosphatase and tensin homologue axis [24], and in the pancreatic cancer, An et al., showed that DLX6-AS1 functioned as an endogenous RNA for miR-181b to promote cancer cell proliferation and invasion [25].